Sangamo Therapeutics (SGMOQ) Goodwill & Intangibles (2013 - 2023)

Sangamo Therapeutics has reported Goodwill & Intangibles for 11 years, with the latest figure at $51.6 million in Q1 2023.

• On a quarterly basis, Goodwill & Intangibles fell 43.73% year-over-year to $51.6 million in Q1 2023; TTM through Mar 2023 was $51.6 million, a 43.73% decrease from a year earlier, with the FY2022 full-year figure at $88.3 million, down 5.54% from the prior year.
• Goodwill & Intangibles was $51.6 million for Q1 2023 at Sangamo Therapeutics, down from $88.3 million in the prior quarter.
• The five-year high for Goodwill & Intangibles was $100.9 million in Q4 2020, with the low at $51.6 million in Q1 2023.
• Average Goodwill & Intangibles over 5 years is $90.1 million, with a median of $92.5 million recorded in 2019.
• The sharpest annual moves came in 2019 and 2023: Goodwill & Intangibles soared 5810.85% in 2019, then plunged 43.73% in 2023.
• Over 5 years, Goodwill & Intangibles stood at $92.4 million in 2019, then gained by 9.19% to $100.9 million in 2020, then dropped by 7.4% to $93.5 million in 2021, then retreated by 5.54% to $88.3 million in 2022, then tumbled by 41.6% to $51.6 million in 2023.
• The last three Goodwill & Intangibles figures came in at $51.6 million (Q1 2023), $88.3 million (Q4 2022), and $81.0 million (Q3 2022), per Business Quant data.